Aclaris Therapeutics, Inc. (ACRS)
Aclaris Therapeutics, Inc., a biopharmaceutical firm operating in the United States, is currently in the clinical development phase, focused on creating novel therapeutic agents for various immune-inflammatory conditions. The company's operations are divided into two primary divisions: the Therapeutics segment, dedicated to discovering and progressing innovative treatments to address crucial unmet needs in immuno-inflammatory disorders; and the Contract Research segment, which delivers specialized laboratory services. The company's pipeline features several investigational compounds. Among these is Zunsemetinib, an MK2 inhibitor, being developed to treat moderate to severe cases of rheumatoid arthritis, psoriatic arthritis, and hidradenitis suppurativa. Another significant candidate is ATI-1777, a soft JAK 1/3 inhibitor, intended for the management of moderate to severe atopic dermatitis. Additionally, Aclaris is advancing ATI-2138, an ITK/TXK/JAK3 inhibitor, as a potential intervention for T cell-mediated autoimmune diseases; a Gut-Biased Program targeting inflammatory bowel disease; and ATI-2231, an MK2 inhibitor, for the treatment of pancreatic and metastatic breast cancer. Established in 2012, Aclaris Therapeutics, Inc. has its corporate headquarters situated in Wayne, Pennsylvania.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Aclaris Therapeutics, Inc.
NASDAQ:ACRSHealthcare · Medical - Diagnostics & Research
-0.50%$3.97
AH$4.03+1.51%vs close
Mkt Cap$615.29M
Float121.51M
O/S154.98M
Vol
$ Vol
RVOL
Inst Own77.0%
SI12.4%
Earnings
Dilution
Financials Summary
Revenue$7.83M
Net Income-$64.92M
Total Assets$160.46M
Free Cash Flow-$47.11M
Debt & Equity
Debt 2%
Equity 98%
Total Debt$2.12M
Total Equity$103.08M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in ACRS's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$160.46M
Liabilities$57.38M
Accounts Receivable$5.57M
Accounts Payable$13.16M
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Revenue | $7.83M | $18.72M | $31.25M | $29.75M | $6.76M | $6.48M | $4.23M | $10.09M | $1.68M | $0 | $0 | $0 | $0 |
| YoY Growth | -58.2% | -40.1% | 5.0% | 340.1% | 4.3% | 53.3% | -58.1% | 499.6% | - | - | - | - | - |
| Cost of Revenue | $2.09M | $2.79M | $18.08M | $11.96M | $4.71M | $5.13M | $4.05M | $6.85M | $1.21M | $120K | $90K | $0 | $0 |
| Gross Profit | $5.74M | $15.93M | $13.17M | $17.79M | $2.05M | $1.35M | $172K | $3.24M | $476K | -$120K | -$90K | $0 | $0 |
| Gross Margin | 73.3% | 85.1% | 42.1% | 59.8% | 30.3% | 20.8% | 4.1% | 32.1% | 28.3% | - | - | - | - |
| Research and Development | $52.65M | $33.59M | $98.38M | $77.81M | $43.81M | $29.34M | $64.9M | $63.01M | $39.79M | $33.48M | $15.34M | $6.51M | $3.49M |
| Selling, General, and Administrative | $21.97M | $22.2M | $31.1M | $25.13M | $23.62M | $20.53M | $27.83M | $75.65M | $33.11M | $15.09M | $5.33M | $2.03M | $1.77M |
| Other | $7.49M | $102.07M | -$18.96M | $4.7M | $24.34M | $2.39M | $0 | $0 | $0 | $488K | $0 | $0 | $0 |
| Total Operating Expenses | $82.11M | $157.86M | $110.53M | $107.65M | $91.77M | $52.26M | $92.73M | $138.66M | $72.9M | $48.57M | $20.67M | $8.53M | $5.26M |
| Operating Income (EBIT) | -$76.38M | -$141.93M | -$97.36M | -$89.85M | -$89.72M | -$50.91M | -$111.06M | -$135.41M | -$72.42M | -$48.57M | -$20.67M | -$8.53M | -$5.26M |
| Operating Margin | -975.9% | -758.2% | -311.6% | -302.0% | -1327.1% | -785.4% | -2627.3% | -1341.9% | -4303.2% | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $7.64M | $7.95M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $104K | $16K | $21K |
| Other Income (Expense) | $11.45M | $9.87M | $8.51M | $2.95M | -$1.14M | -$424K | -$2.48M | $2.68M | -$15.99M | $488K | $104K | $16K | $21K |
| Income Before Tax (EBT) | -$64.92M | -$132.06M | -$88.85M | -$86.91M | -$90.86M | -$51.34M | -$113.54M | -$132.74M | -$70.35M | -$48.08M | -$20.56M | -$8.52M | -$5.24M |
| Income Tax Expense | $0 | $0 | -$367K | $0 | $0 | -$182K | $0 | $2.68M | -$1.83M | -$120K | -$90K | $0 | $0 |
| Net Income | -$64.92M | -$132.06M | -$88.48M | -$86.91M | -$90.86M | -$51.02M | -$161.35M | -$132.74M | -$68.52M | -$48.08M | -$20.56M | -$8.52M | -$5.24M |
| Net Income Margin | -829.6% | -705.5% | -283.1% | -292.1% | -1344.0% | -787.0% | -3817.2% | -1315.4% | -4071.5% | - | - | - | - |
| Supplementary Data | |||||||||||||
| EPS | -0.53 | -1.71 | -1.27 | -1.33 | -1.60 | -1.20 | -3.46 | -4.03 | -2.44 | -2.25 | -1.10 | -0.80 | -3.13 |
| Diluted EPS | -0.53 | -1.71 | -1.27 | -1.33 | -1.60 | -1.20 | -3.46 | -4.03 | -2.44 | -2.25 | -1.10 | -0.80 | -3.13 |
| Weighted Average OS | 122.66M | 77.30M | 69.81M | 65.21M | 56.73M | 42.54M | 41.32M | 32.91M | 28.10M | 21.42M | 18.62M | 10.66M | 1.68M |
| EBITDA | -$64.47M | -$51.72M | -$115.45M | -$84.36M | -$64.46M | -$47.2M | -$90.23M | -$83.46M | -$53.45M | -$48.57M | -$20.67M | -$8.52M | -$5.25M |
| EBITDA Margin | -823.8% | -276.3% | -369.5% | -283.5% | -953.4% | -728.1% | -2134.7% | -827.0% | -3176.1% | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash and Cash Equivalents | $19.96M | $24.57M | $39.88M | $45.28M | $27.35M | $22.06M | $34.19M | $57.02M | $208.85M | $30.17M | $9.85M | $10.76M | $9.59M |
| Short-Term Investments | $70.79M | $89.02M | $79.23M | $172.29M | $164.06M | $32.07M | $39.08M | $110.95M | $0 | $107.05M | $75.02M | $5.37M | $3.74M |
| Cash and Short-Term Investments | $90.75M | $113.59M | $119.11M | $217.57M | $191.41M | $54.13M | $73.27M | $167.97M | $208.85M | $174.13M | $92.04M | $16.13M | $13.32M |
| Accounts Receivable | $5.57M | $318K | $298K | $484K | $623K | $772K | $704K | $563K | $481K | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $791K | -$6.36M | $0 | $0 | $0 | $0 |
| Other Current Assets | $55.05M | $12.04M | $9.45M | $13.49M | $0 | $0 | $6.72M | $5.37M | $5.88M | $1.33M | $1.66M | $0 | $0 |
| Total Current Assets | $151.36M | $125.95M | $128.86M | $231.55M | $205.03M | $57.49M | $83.8M | $179.5M | $208.85M | $174.13M | $92.04M | $16.33M | $13.39M |
| Long-Term Assets | |||||||||||||
| Property, Plant & Equipment Net | $0 | $1.01M | $1.62M | $1.1M | $1.33M | $1.65M | $2.47M | $4.28M | $2.16M | $481K | $360K | $515K | $19K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $18.5M | $18.5M | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $269K | $6.97M | $7.05M | $7.12M | $7.2M | $72.95M | $7.35M | $0 | $0 | $0 | $0 |
| Long-Term Investments | $60.61M | $90.3M | $62.77M | $12.24M | $34.24M | $0 | $0 | $0 | $15M | $36.91M | $7.17M | $518K | $802K |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$8.63M | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | -$51.52M | $3.07M | $3.89M | $2.73M | $3.55M | $4.51M | $4.83M | $332K | $279K | -$35.44M | -$5.49M | $10K | $0 |
| Total Long-Term Assets | $9.1M | $94.38M | $68.55M | $23.05M | $46.18M | $13.29M | $14.49M | $96.07M | $34.66M | $1.95M | $2.04M | $1.04M | $821K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $160.46M | $220.33M | $197.41M | $254.6M | $251.21M | $70.78M | $98.3M | $275.57M | $243.51M | $176.09M | $94.08M | $17.38M | $14.21M |
| Liabilities | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | $13.16M | $4.69M | $8.88M | $10.35M | $9.98M | $5.25M | $9.92M | $11.68M | $7.82M | $2.85M | $810K | $1.26M | $353K |
| Short-Term Debt | $551K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $3.94M | $3.89M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $5.7M | $11.59M | $6.11M | $7.5M | $6.59M | $7.08M | $7.48M | $7.44M | $0 | $100K | $0 | $0 | $0 |
| Total Current Liabilities | $28.64M | $31.6M | $30.95M | $21.94M | $22.93M | $14.87M | $22.43M | $27.34M | $12.76M | $6.22M | $1.55M | $1.45M | $367K |
| Long-Term Liabilities | |||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $10.65M | $0 | $29.91M | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $16.17M | $20.04M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $367K | $367K | $367K | $549K | $549K | $549K | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $11M | $13.14M | $9.27M | $34.67M | $30.57M | $7.24M | $5.4M | $2.64M | $4.94M | $372K | $0 | $36.68M | $23M |
| Total Long-Term Liabilities | $28.73M | $33.18M | $9.27M | $35.04M | $30.94M | $18.26M | $5.95M | $33.1M | $5.49M | $372K | $0 | $36.68M | $23M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $57.38M | $64.77M | $40.23M | $56.98M | $53.87M | $33.13M | $28.39M | $60.44M | $18.25M | $6.59M | $1.55M | $38.13M | $23.37M |
| Stockholders' Equity | |||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $36.68M | $23M |
| Common Stock | $1K | $1K | $1K | $1K | $1K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$967.78M | -$902.86M | -$770.8M | -$682.32M | -$595.41M | -$504.54M | -$453.53M | -$292.17M | -$159.44M | -$90.91M | -$42.83M | -$20.75M | -$9.17M |
| Comprehensive Income & Other | $610K | $97K | -$106K | -$897K | -$224K | -$94K | -$66K | -$69K | -$246K | -$269K | -$149K | -$6K | $3K |
| Other Stockholders' Equity | $1.07B | $1.06B | $927.97M | $879.93M | $792.75M | $542.19M | $523.44M | $507.3M | $384.7M | $260.4M | $135.35M | -$6K | $3K |
| Total Equity | $103.08M | $155.55M | $157.18M | $197.62M | $197.34M | $37.65M | $69.91M | $215.12M | $225.26M | $169.49M | $92.52M | -$20.75M | -$9.16M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $160.46M | $220.33M | $197.41M | $254.6M | $251.21M | $70.78M | $98.3M | $275.57M | $243.51M | $176.09M | $94.08M | $17.38M | $14.21M |
| Supplementary Data | |||||||||||||
| Total Debt | $2.12M | $0 | $426K | $684K | $693K | $11.26M | $637K | $30.52M | $142K | $0 | $0 | $0 | $0 |
| Net Debt | -$17.84M | -$24.57M | -$39.45M | -$44.59M | -$26.66M | -$10.81M | -$33.55M | -$26.5M | -$208.71M | -$30.17M | -$9.85M | -$10.76M | -$9.59M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Operating Activities | |||||||||||||
| Net Income | -$64.92M | -$132.06M | -$88.48M | -$86.91M | -$90.86M | -$51.02M | -$113.54M | -$132.74M | -$68.52M | -$48.08M | -$20.56M | -$8.52M | -$5.24M |
| Depreciation & Amortization | $454K | $807K | $863K | $797K | $923K | $1.32M | $1.59M | $1.32M | $402K | $120K | $90K | $12K | $11K |
| Deferred Income Tax | $0 | $0 | -$367K | $0 | $752K | -$182K | $0 | $0 | -$1.84M | $216K | $289K | $0 | $0 |
| Stock-Based Compensation | $12.38M | $10.86M | $20.54M | $15.04M | $14.06M | $11.21M | $0 | $20.05M | $14.43M | $6.1M | $891K | $27K | $0 |
| Changes in Working Capital: | |||||||||||||
| Accounts Receivable | $6.14M | -$20K | $186K | $139K | $149K | $4.9M | -$809K | -$4.38M | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $605K | $102K | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $8.45M | -$4.19M | -$1.47M | $368K | $3.65M | -$5.22M | -$3.16M | $6.96M | $4.56M | $1.81M | -$359K | $819K | $303K |
| Other Working Capital | -$11.91M | $15.13M | $10.68M | -$1.7M | -$5.15M | -$2.04M | $661K | $6.75M | -$3.7M | $2.44M | -$712K | $22K | -$1K |
| Total Working Capital Change | $2.67M | $10.92M | $9.39M | -$1.2M | -$1.34M | -$2.36M | -$2.7M | $9.44M | $865K | $4.25M | -$1.07M | $841K | $302K |
| Other Non-Cash Items | $2.3M | $89.41M | -$20.27M | $4.7M | $24.34M | $2.39M | $18.21M | $1.11M | $10.67M | $2.78M | -$5K | $1K | $3K |
| Net Cash from Operating | -$47.11M | -$20.07M | -$78.33M | -$67.57M | -$52.13M | -$38.63M | -$96.44M | -$100.81M | -$54.66M | -$34.6M | -$20.37M | -$7.64M | -$4.92M |
| Investing Activities | |||||||||||||
| Capital Expenditures | -$111K | -$121K | -$1.31M | -$605K | -$308K | -$453K | -$1.61M | -$1.36M | -$1.24M | -$232K | -$507K | -$417K | $0 |
| Acquisitions | $0 | $0 | $0 | -$13.23M | $167.32M | $0 | $0 | -$67.12M | -$9.65M | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$39.73M | -$119.98M | -$135.68M | -$164.75M | -$235.15M | -$47.71M | -$137.38M | -$161.6M | -$197.34M | -$148.76M | -$82.51M | -$5.04M | -$4.54M |
| Sales of Investments | $89.04M | $86.14M | $183.2M | $177.99M | $67.83M | $54.55M | $210.49M | $239.44M | $152.53M | $87.09M | $6.07M | $3.67M | $0 |
| Other Investing Activities | -$833K | -$35.81M | $0 | $13.23M | -$167.32M | $0 | $34.19M | $77.84M | -$44.81M | -$61.67M | -$76.44M | -$1.36M | -$4.54M |
| Net Cash from Investing | $48.37M | -$69.77M | $46.22M | $12.63M | -$167.63M | $6.39M | $105.68M | $9.37M | -$55.69M | -$61.9M | -$76.95M | -$1.78M | -$4.54M |
| Financing Activities | |||||||||||||
| Debt Repaid | - | - | - | - | $11.48M | -$10.78M | $30.52M | -$29.26M | $78K | - | - | - | - |
| Common Stock Issuance | $0 | $74.91M | $26.71M | $72.74M | $238.2M | $7.74M | $207K | $100.2M | $100.23M | $116.7M | $56.55M | $0 | $0 |
| Common Stock Repurchases | -$446K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$5.42M | -$377K | -$8K | $123K | -$1.67M | -$141K | $0 | -$1.21M | $235K | $121K | $0 | $0 | $0 |
| Net Cash from Financing | -$5.86M | $74.54M | $26.71M | $72.87M | $225.05M | $18.37M | -$30.32M | $128.26M | $100.39M | $116.83M | $96.41M | $10.58M | $0 |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$4.61M | -$15.31M | -$5.4M | $17.93M | $5.29M | -$13.87M | -$21.08M | $36.82M | -$9.97M | $20.32M | -$906K | $1.17M | -$9.46M |
| Supplementary Data | |||||||||||||
| Operating Cash Flow | -$47.11M | -$20.07M | -$78.33M | -$67.57M | -$52.13M | -$38.63M | -$96.44M | -$100.81M | -$54.66M | -$34.6M | -$20.37M | -$7.64M | -$4.92M |
| Capital Expenditure | -$111K | -$121K | -$1.31M | -$605K | -$308K | -$453K | -$1.61M | -$1.36M | -$1.24M | -$232K | -$507K | -$417K | $0 |
| Free Cash Flow | -$47.11M | -$20.2M | -$79.63M | -$68.17M | -$52.44M | -$39.09M | -$98.06M | -$102.17M | -$55.9M | -$34.84M | -$20.88M | -$8.05M | -$4.92M |
| Cash at Beginning | $24.57M | $39.88M | $45.28M | $27.35M | $22.06M | $35.94M | $57.02M | $20.2M | $30.17M | $9.85M | $10.76M | $9.59M | $19.04M |
| Cash at End | $19.96M | $24.57M | $39.88M | $45.28M | $27.35M | $22.06M | $35.94M | $57.02M | $20.2M | $30.17M | $9.85M | $10.76M | $9.59M |